Skip to main content

Table 5 Impairment in work productivity in employed patients (WPAI:IBS-C questionnaire) and daily activities in all patients with moderate to severe IBS-C at baseline and 6 months

From: Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries

   FRANCE GERMANY ITALY SPAIN SWEDEN UK
  Total 59 102 112 112 36 104
Presenteeism, % a N 27 52 66 45 24 58
Baseline 44.4 (32.9) 35.6 (28.2) 27.6 (27.7) 29.2 (27.5) 41.3 (22.1) 47.9 (28.7)
N 15 49 65 49 20 41
6 Months 43.3 (27.7) 32.2 (24.9) 25.4 (21.4) 27.1 (23.9) 34.0 (21.4) 38.0 (28.0)
Absenteeism, %a N 21 43 63 46 22 51
Baseline 18.5 (34.9) 14.7 (28.2) 3.1 (9.3) 6.1 (15.8) 6.9 (12.4) 8.4 (24.2)
N 9 33 60 49 18 38
6 Months 0.9 (2.8) 3.2 (9.1) 0.9 (3.7) 2.9 (5.0) 2.7 (6.7) 7.0 (22.6)
Overall work productivity loss, %a N 21 43 62 50 22 49
Baseline 46.3 (33.2) 44.1 (32.7) 27.7 (28.6) 32.3 (27.2) 44.4 (24.9) 51.5 (27.2)
N 9 33 60 55 18 37
6 Months 39.6 (29.3) 32.0 (25.7) 26.1 (22.0) 29.8 (24.0) 32.4 (20.2) 39.1 (27.2)
Daily activity impairment, % N 52 95 110 104 35 99
Baseline 48.1 (29.0) 36.3 (24.8) 41.1 (29.1) 39.6 (27.2) 48.0 (25.4) 56.8 (29.6)
N 37 92 105 97 30 72
6 Months 50.5 (28.2) 38.0 (23.3) 33.0 (25.1) 37.9 (26.3) 43.0 (28.4) 51.4 (31.7)
  1. aEmployed patients. All values are presented as mean (SD)